SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition

Aggressive lethal prostate cancer is characterised by tumour invasion, metastasis and androgen resistance. Understanding the mechanisms by which localised disease progresses to advanced lethal stages is key to the development of effective therapies. Here we have identified a novel role for the trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jeffrey C., Capper, Amy, Ning, Jian, Knight, Eleanor, de Bono, Johann, Swain, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800928/
https://www.ncbi.nlm.nih.gov/pubmed/29484136
http://dx.doi.org/10.18632/oncotarget.24123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800928/
https://www.ncbi.nlm.nih.gov/pubmed/29484136
http://dx.doi.org/10.18632/oncotarget.24123

Ejemplares similares